GLYCATED HEMOGLOBIN AND FRUCTOSAMINE IN NONDIABETIC SUBJECTS WITH CHRONIC-RENAL-FAILURE

被引:19
|
作者
MORGAN, LJ
MARENAH, CB
MORGAN, AG
BURDEN, RP
JOHN, WG
机构
[1] CITY HOSP NOTTINGHAM, DEPT RENAL MED, NOTTINGHAM NG5 1PD, ENGLAND
[2] NEW CROSS HOSP, DEPT CLIN BIOCHEM, WOLVERHAMPTON WV10 0QP, W MIDLANDS, ENGLAND
关键词
CHRONIC RENAL FAILURE; FRUCTOSAMINE; GLYCATED HEMOGLOBIN;
D O I
10.1093/ndt/5.10.868
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Measurements of glycated haemoglobin by electroendosmotic and chromatographic methods, fructosamine, and fructosamine:albumin ratio were made in 91 non-diabetic subjects with chronic renal failure managed conservatively (n = 25), by continuous ambulatory peritoneal dialysis (n = 22), by haemodialysis (n = 22), or by renal transplantation (n = 22). Results were compared with those in a control group of 43 non-diabetic subjects with normal renal function. Mean glycated haemoglobin measured by electroendosmosis was significantly greater in all groups with chronic renal failure except the transplant group. Mean glycated haemoglobin measured by affinity chromatography was not significantly different from controls in any of the groups with chronic renal failure. No difference in mean fructosamine concentration was detected in the transplant or conservatively managed groups compared to controls, but values were significantly lower in the CAPD group, and greater in the haemodialysis group predialysis. Post-haemodialysis samples showed a significant reduction in mean fructosamine concentration when compared with prehaemodialysis samples. Fructosamine:albumin ratios were elevated in all groups of patients with renal failure, with the exception of the transplant group. Of the four indices of glycaemic control considered in this study, only glycated haemoglobin measured by affinity chromatography appears to be unaffected by chronic renal failure.
引用
收藏
页码:868 / 873
页数:6
相关论文
共 50 条
  • [1] GLYCATED HEMOGLOBIN AND FRUCTOSAMINE IN DIABETIC AND NONDIABETIC CATS
    AKOL, KG
    WADDLE, JR
    WILDING, P
    JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION, 1992, 28 (03) : 227 - 231
  • [2] PREVENTION OF PROGRESSION IN NONDIABETIC CHRONIC-RENAL-FAILURE
    BECKER, GJ
    WHITWORTH, JA
    IHLE, BU
    SHAHINFAR, S
    KINCAIDSMITH, PS
    KIDNEY INTERNATIONAL, 1994, 45 : S167 - S170
  • [3] GLYCOSYLATED HEMOGLOBIN IN CHRONIC-RENAL-FAILURE
    NATH, SS
    NAYAK, BR
    PATTABIRAMAN, TN
    INDIAN JOURNAL OF MEDICAL RESEARCH, 1982, 75 (JUN) : 846 - 849
  • [4] GLYCOSYLATED HEMOGLOBIN IN CHRONIC-RENAL-FAILURE
    GRASSI, R
    MACCHIA, M
    DAZZI, F
    MINERVA MEDICA, 1981, 72 (4-5) : 233 - 236
  • [5] GLYCOSYLATED HEMOGLOBIN IN CHRONIC-RENAL-FAILURE
    GRAF, H
    STUMMVOLL, HK
    MULLER, MM
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1980, 18 (10): : 686 - 686
  • [6] FRUCTOSAMINE OR GLYCATED HEMOGLOBIN
    MORLEY, JE
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1989, 37 (09) : 911 - 912
  • [7] Association of glycated hemoglobin with hemoglobin levels in elderly nondiabetic subjects
    Grossman, Alon
    Gafter-Gvili, Anat
    Schmilovitz-Weiss, Hemda
    Koren-Morag, Nira
    Beloosesky, Yichayaou
    Weiss, Avraham
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 36 : 32 - 35
  • [8] GLYCATED PLASMA-PROTEINS IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    BORDASFONDREDE, M
    SAUSER, E
    JARDEL, C
    JAUDON, MC
    THERVET, F
    ROTTEMBOURG, J
    DELATTRE, J
    ANNALES DE BIOLOGIE CLINIQUE, 1990, 48 (10) : 717 - 721
  • [9] PHARMACOKINETICS OF GITOFORMATE IN SUBJECTS WITH CHRONIC-RENAL-FAILURE
    DEICAS, L
    BARILLI, AL
    ROSSI, E
    ASTORRI, E
    VISIOLI, O
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1980, 6 (03) : 215 - 220
  • [10] INCREASED LP(A) IN SUBJECTS WITH CHRONIC-RENAL-FAILURE
    GRUBER, KK
    HAFFNER, SM
    TUTTLE, KR
    CLINICAL RESEARCH, 1992, 40 (02): : A433 - A433